To define the events proximal to DNA damage that might contribute to the immunomodulatory effects of cisplatin versus carboplatin, we treated 5637 bladder cancer cells with increasing concentrations of the platinum drugs and probed the impact on DNA damage transducers ATM and ATR. This evidence concerns the gene ATM and urinary bladder cancer.